Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07190859 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic

StatusActive, Not Recruiting
PhaseNot applicable
SponsorBioGaia AB
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 8 months later Feb 17, 2026 → Oct 17, 2027
See other at-risk trials from BioGaia AB

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Feb 17, 2026 to Oct 17, 2027 Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Aug 30, 2026 to Oct 30, 2027
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: details revised at 3 of 5 entries
    • Site details revised at 4 of 4 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BioGaia AB
8 trials monitored
See 1 trial at risk
This is a double-blind, randomized, placebo-controlled, parallel-group study in infants with colic with the primary objective to evaluate crying and fussing time.
Trial Details
NCT Number NCT07190859
Lead Sponsor BioGaia AB
Conditions
(from sponsor)		 Infantile Colic
Related terms Colic
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov